ARCHIVES

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

NIH reauthorization Bill slates For House Vote;

May 28, 1993

HHS Reinvention May Include Privatizing Of NIH Clinical Center

May 19, 1995

NIH To Site Visit Animal Facilities

March 18, 1983

White House Seek Elimination Of NCI’s Bypass Budget Authority In Legislation Renewing Cancer Act

April 9, 1982

Physicians Not Giving Enough Narcotics For Effective Pain Control, M.D. Anderson Specialist Tells Seminar

April 14, 1989

NCI’s New Policy On Costly Research

December 10, 1993